Live Breaking News & Updates on Managing Director Krishna Ella

Stay updated with breaking news from Managing director krishna ella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bharat Biotech, ExcellGene and University of Sydney ink pact to develop variant-proof COVID vaccine

New Delhi: Swiss biologics contract development and manufacturing organisation ExcellGene SA on Tuesday said it has partnered with Bharat Biotech and the University of Sydney to develop a. ....

New South Wales , New Delhi , Jamie Triccas , Mariaj Wurm , Krishna Ella , Coalition For Epidemic Preparedness Innovations , University Of Sydney , Bharat Biotech , Epidemic Preparedness Innovations , Prof Jamie Triccas , Bharat Biotech Chairman , Managing Director Krishna Ella , Coronavirus Vaccine ,

Covid-19 fourth wave: 'Single, variant-proof' vaccine coming soon!

CEPI will fund the initiative under its USD 200 million programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other betacoronaviruses. ....

New South Wales , New Delhi , Richard Hatchett , Krishna Ella , Bharat Biotech International , Coalition For Epidemic Preparedness Innovations , University Of Sydney , Bharat Biotech , Epidemic Preparedness Innovations , Switzerland Based Excellgene , Biotech Chairman , Managing Director Krishna Ella ,

Bharat Biotech To Get $19 Million For Development Of 'Variant Proof' Covid Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a "variant-proof" SARS-CoV-2 vaccine candidate. ....

New South Wales , Richard Hatchett , Krishna Ella , Bharat Biotech International , Coalition For Epidemic Preparedness Innovations , University Of Sydney , Covaxin Maker Gets , Variant Proof Vaccine , Epidemic Preparedness Innovations , Switzerland Based Excellgene , Bharat Biotech , Biotech Chairman , Managing Director Krishna Ella ,

India News | Bharat Biotech's Covaxin Gets Emergency Approval for 6-12 Age Group

Get latest articles and stories on India at LatestLY. Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12 years of age in India.
India News | Bharat Biotech s Covaxin Gets Emergency Approval for 6-12 Age Group. ....

New Delhi , Tamil Nadu , Krishna Ella , World Health Organization , Bharat Biotech International Ltd , Central Drugs Standard Control Organisation , Bharat Biotech , Year Old Man Charged With Murder , His Maternal Uncle , Bharat Biotech Chairman , Managing Director Krishna Ella , Emergency Use Listing ,

Three Cities and One Mission - Open The Magazine

Three Cities and One Mission - Open The Magazine
openthemagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openthemagazine.com Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , New Delhi , Natasha Poonawalla , Cyrus Poonawalla , Zydus Cadila , Bharat Immunologicals , Sharvil Patel , Hester Biosciences , Pankaj Patel , Krishna Ella , Adar Poonawalla , Suchitra Ella , Indian Air Force , Indian Immunologicals , Haffkine Biopharmaceutical Corporation Ltd , Serum Institute Of India , Gujarat Biotechnology Research Centre , Ministry Of Science , Zydus Biotech Park , Chairman Pankaj Patel , Bharat Biotech , Genome Valley , Managing Director Krishna Ella , Joint Managing Director Suchitra Ella , Serum Institute , Biopharmaceutical Corporation Ltd ,